Advanced Flower Capital (AFCG) Q4 2025 earnings review
BDC Conversion Complete, But Legacy Loans Drag Earnings Negative
Advanced Flower Capital successfully completed its strategic conversion from a cannabis-focused REIT to an industry-agnostic Business Development Company (BDC) on January 1, 2026. However, the financial toll of cleaning up its legacy cannabis portfolio is severe. Distributable Earnings reversed sharply to a negative $2.8 million ($(0.12) per share) in Q4, down from positive $6.3 million a year ago. While GAAP Net Income was slightly positive at $0.9 million, this was driven by a $3.5 million non-cash unrealized gain. Management has effectively reset shareholder expectations, initiating a heavily reduced $0.05 per share dividend for Q1 2026 after suspending it entirely in Q4.
🐂 Bull Case
The structural conversion to a BDC is complete. AFC can now deploy capital into non-cannabis, lower-middle-market businesses, offering flexible structures (unsecured, convertible, equipment financing) that the legacy REIT model prohibited.
Taking the earnings hit now allows management to resolve underperforming legacy cannabis positions. The company retains ample liquidity with $38.6 million in cash and a reduced overall debt burden.
🐻 Bear Case
Distributable Earnings, the core metric for dividend sustainability, turned deeply negative. The historical cannabis loan book continues to require substantial workouts, impacting cash flows.
Income investors have suffered a massive yield reduction. The declared Q1 2026 dividend of $0.05 is an 85% cut compared to the $0.33 payout just four quarters ago.
⚖️ Verdict: 🔴
Bearish. While the BDC transition offers a viable long-term survival path, the current financials reflect a painful restructuring phase. Negative core earnings and a slashed dividend outweigh the optimistic narrative around future pipeline deployments.
Key Themes
Distributable Earnings Turn Negative
A major red flag is the reversal of Distributable Earnings to negative $2.8 million in Q4, down from positive $3.5 million in Q3 and $6.3 million a year ago. Management had previously warned of a ~$4 million taxable loss related to the Private Company P settlement, which appears to have crystallized this quarter. This metric effectively demonstrates that the performing portion of the portfolio is no longer generating enough cash to offset the losses from legacy non-accrual loans.
Expanded BDC Mandate Commences
The successful conversion to a BDC on January 1, 2026, is the company's primary growth driver. By shedding the restrictive commercial mortgage REIT structure, AFC can now target a much broader universe of U.S. lower middle-market companies with EBITDA between $5 to $50 million. This allows for sponsor-agnostic originations and more flexible deal structures, directly addressing the pipeline shrinkage experienced in the restricted cannabis market.
Legacy Cannabis Portfolio Overhang
Despite the forward-looking BDC narrative, legacy cannabis loans remain a massive drag. Total expected credit loss (CECL) reserves sit at a staggering $46.1 million against loans held at carrying value. Troubled assets like Justice Grown (Private Company G) and Private Company A continue to tie up capital and management resources, delaying the redeployment into higher-quality, non-cannabis assets.
Dividend Reset Establishes New Floor
After a complete dividend suspension in Q4 2025 to preserve capital amidst loan workouts, the Board declared a $0.05 per share regular cash dividend for Q1 2026. This decelerating trend ($0.33 -> $0.23 -> $0.15 -> $0.00 -> $0.05) reflects management's attempt to establish a highly conservative baseline that can be covered by the significantly reduced performing asset base.
Macro Environment Pressures Cannabis Borrowers
Management's pivot away from cannabis is deeply rooted in macro headwinds: a persistent lack of federal regulatory reform and a severe drought of fresh equity capital entering the space. Without an equity cushion below their debt, lenders like AFC face disproportionate downside risk, justifying the shift toward more recession-resistant industries.
Other KPIs
Stable sequentially compared to $6.5 million in 25Q3, but representing a stark deceleration from $9.2 million in 24Q4. The shrinking top line reflects a smaller performing loan book as management works out defaults and writes off bad legacy debt.
Accelerating significantly from $3.5 million in 24Q4. This was heavily driven by $5.3 million in stock-based compensation (up from $0.26M a year ago) and $0.43 million in one-time BDC conversion expenses.
Reversing to positive from a $12.5 million loss in Q3, but this is an accounting illusion. The positive result was entirely driven by a $3.5 million non-cash unrealized gain on loans at fair value, masking the negative cash generation of the quarter.
Guidance
Decelerating severely on a year-over-year basis (down from $0.23 in Q1 2025), though technically an acceleration from the $0.00 paid in Q4 2025. This establishes a new, ultra-conservative floor for shareholder returns under the new BDC model.
Key Questions
Path to Positive Distributable Earnings
With Q4 Distributable Earnings falling to negative $2.8 million, what is the specific timeline and minimum required new origination volume needed to return this core metric to positive territory in 2026?
Non-Cannabis Deployment Pace
Now that the BDC conversion is complete, how quickly do you expect to close deals from your previously stated $350M+ non-cannabis pipeline, and what are the target yields on these new originations?
Status of Major Loan Workouts
Can you provide a definitive update on the capital recovery timelines for the Justice Grown (Private Company G) litigation and the Private Company K asset sales, and quantify any further potential losses?